india tirzepatide 🚨 Obesity & Diabetes Breakthrough: Mounjaro (Tirzepatide) Now in India! 🚨 Big news! Mounjaro (Tirzepatide) is now available in for type 2 diabetes & weight management. This dual GLP-1 & GIP The skinny-pen tsunami: India on

The agency indicated the drug should be used in addition to a reduced calorie diet and exercise

It often starts with initial success and is followed by frustration when plateaus happen

Published studies included oral and intravenous routes, while community plans often discuss subcutaneous forms

These include: Neuroprotection : Reducing oxidative stress and inflammation that contribute to dopaminergic neuron death Mitochondrial support : Enhancing cellular energy production, which is often impaired in Parkinson's Protein clearance : Potentially improving the removal of toxic protein aggregates like alpha-synuclein Metabolic benefits : Addressing insulin resistance and glucose dysregulation, which may influence neurodegeneration However, these potential advantages must be weighed against known adverse effects of GLP-1 receptor agonists

In Canada it is currently only formally approved for the treatment of type 2 diabetes (Mounjaro), while in the US it is also approved for the treatment of obesity (Zepbound)

This medicine acts like the GLP-1 hormone in your body